Cytarabine

Cytarabine, cytarabine, 147-94-4, Ara-C, Cytosine arabinoside, Aracytidine, Cytarabinoside, Arabinocytidine, Spongocytidine, Aracytin, Alexan, Depocyt, Udicil, Cytosar-U, Aracytine, Arabitin, Erpalfa, Cytarabina, Arafcyt, Cytosine beta-D-arabinofuranoside, 1-beta-D-Arabinofuranosylcytosine, DepoCyte, arabinocytosine, Citarabina, Cytarabinum, Cytosar, Arabinofuranosylcytosine, Cytosine-beta-D-arabinofuranoside, Cytosinearabinoside, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone, Arabinosylcytosine, beta-D-Arabinosylcytosine, Cytarabin, Cytosine arabinofuranoside, Cytosine beta-D-arabinoside, Arabinoside C, 1beta-D-Arabinosylcytosine, Cytosine-1-beta-D-arabinofuranoside, Cytosine arabinose, cytarabine liposome, 1beta-Arabinofuranasylcytosine, Beta-cytosine arabinoside, Cytosine 1-beta-D-arabinofuranoside, 1beta-D-Arabinofuranosylcytosine, 1-beta-D-Arabinofaranosylcytosine, beta-Arabinosylcytosine, Ara-Cytidine, U 19920A, Cytosine-beta-arabinoside, 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one, U-19,920, 1-Arabinofuranosylcytosine, Cytosine, 1-beta-D-arabinosyl-, 1-beta-D-Arabinosylcytosine, 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, Cytosine, 1-beta-D-arabinofuranosyl-, 1-beta-arabinofuranosylcytosine, U-19920, DTXSID3022877, CHEBI:28680, 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin, 04079A1RDZ, Arabinofuranosyl Cytidine, NSC-287459, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-, DTXCID702877, NCI-C04728, VYXEOS COMPONENT CYTARABINE, 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine, AC-1075, NSC287459, Cytarbel, Cytosar U, Tarabine PFS, Ara C, Ara-cell, Arabine, CHX-3311, NSC 63878, 4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one, beta Ara C, 1-(beta-d-arabinofuranosyl)cytosine, 4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one, cytarabine ocphosphate, Arabinoside, Cytosine, Alexan 100, RefChem:5727, U 19920, 2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-, L01BC01, WR-28453, 205-705-9, 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one, Starasid, Tarabine, 4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, Cytarabinum [INN-Latin], Citarabina [INN-Spanish], AraC, MFCD00066487, Cytosine |A-D-Arabinofuranoside, Depocyt (liposomal), C9H13N3O5, CHEMBL803, 2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-, AR3, CHX 3311, 1-beta-D-arabinofuranosyl-cytosine, CCRIS 913, HSDB 3049, NCGC00093356-03, 2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS], Cytonal, NSC 287459, beta-Ara C, AI3-52329, Cytosine arabinoside (VAN), (beta-D-Arabinofuranosyl)cytosine, Cytosine beta-D-arabinofuranoside hydrochloride, Cytarabine Impurity, cytarabine liposome injection, Arabinosyl Cytosine, Cytosine, beta-D-arabinoside, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, CAS-147-94-4, SMR000449317, Depocyt (TN), EINECS 205-705-9, 1-(arabinofuranosyl)cytosine, Cytartbine, UNII-04079A1RDZ, 1-.beta.-D-Arabinofuranosylcytosine, Cytarabine, 4-amino-1-beta-d-arabinofuranosylpyrimidin-2(1H)-one, SR-01000075773, Cytarabine RS, Cytarabine CRS, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech], 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech], 1-.beta.-D-arabinofuranosyl-cytosine, 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon, 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside, Cytarabine [USAN:USP:INN:BAN:JAN], MK 8242, Cytarabine (Standard), beta -arabinosylcytosine, Arabinofuranosylcytosine?, CYTARABINE [MI], CYTARABINE [INN], CYTARABINE [JAN], CYTARABINE [HSDB], CYTARABINE [USAN], beta -cytosine arabinoside, beta -D-arabinosylcytosine, Cytosine-beta -arabinoside, CYTARABINE [VANDF], Epitope ID:768768, CYTARABINE [MART.], SCHEMBL3140, 1beta -D-Arabinosylcytosine, CYTARABINE [USP-RS], CYTARABINE [WHO-DD], CYTARABINE [WHO-IP], BIDD:PXR0139, Lopac0_000316, MLS000758310, MLS001066340, MLS001424023, 1-beta-D-Arabinosyl-Cytosine, BIDD:GT0371, CYTARABINE [EMA EPAR], cytosine-b-D-arabinofuranoside, Cytosine, beta -D-arabinoside, 1beta -Arabinofuranasylcytosine, Cytarabine (JP18/USP/INN), Cytarabine - Bio-X trade mark, GTPL4827, orb1309161, orb3141269, 1-ss-D-Arabinofuranosylcytosine, CYTARABINE [ORANGE BOOK], SCHEMBL22591193, SCHEMBL23152019, 1beta -D-Arabinofuranosylcytosine, CYTARABINE [EP MONOGRAPH], CYTARABINE [USP IMPURITY], 1-(b-D-Arabinofuranosyl)cytosine, Cytosine, 1-beta -D-arabinosyl-, 1-beta -d-arabinofuranosylcytosine, 1-beta-D-arabinofuranosyl cytosine, CYTARABINE [USP MONOGRAPH], Cytosine-beta -D-arabinofuranoside, GLXC-07791, HMS2051K19, HMS2090A18, HMS2230M16, HMS3713N12, 1-beta -D-Arabinofaranosylcytosine, CYTARABINE LIPOSOME [VANDF], CYTARABINUM [WHO-IP LATIN], Tox21_111203, Tox21_301971, BDBM50087289, CCG-51297, EBC-13057, HY-13605R, MSK001344, s1648, AKOS007930145, AKOS015896896, Cytosine, 1-beta -D-arabinofuranosyl-, DB00987, KS-5063, MSK001344-100W, NA05771, NC00070, SDCCGSBI-0050304.P002, Cytarabine Solution in Water, 100ug/mL, NCGC00093356-04, NCGC00093356-05, NCGC00093356-06, NCGC00093356-19, NCGC00142483-02, NCGC00255381-01, BA164339, HY-13605, SRI-10828-19, SRI-10828-20, SRI-10828_24, SY004943, SL-000002, C2035, NS00005949, SW197450-5, C02961, D00168, EN300-118320, 1-BETA-D-ARABINOFURANOSYLCYTOSINE, ARA-C, F222319, Q180983, SR-01000721860, SR-01000075773-3, SR-01000075773-5, SR-01000721860-6, 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl, 4-Amino-1-(b-D-Arabinofuranosyl)-2(1H)pyrimidinone, 4-Amino-1-|_-D-arabinofuranosyl-2(1H)-pyrimidinone, BRD-K33106058-001-07-7, BRD-K33106058-001-16-8, BRD-K33106058-003-20-6, 2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-, Cytosine -D-arabinofuranoside, Cytosine Arabinoside, Ara-C, Z1511499171, 2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-, Cytarabine, European Pharmacopoeia (EP) Reference Standard, Cytarabine, United States Pharmacopeia (USP) Reference Standard, Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC), Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%, Cytarabine, Pharmaceutical Secondary Standard, Certified Reference Material, Cytosine -D-arabinofuranoside hydrochloride, Cytosine Arabinoside hydrochloride, Ara-C hydrochloride